Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Antimicrobial Agents|December 19, 2000
Resistance to antiretroviral drugs in patients with primary HIV-1 infection. Investigators of the Quebec Primary Infection StudyB Brenner, M A Wainberg, H Salomon, et al.
HIV Medicine|May 16, 2018
Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre studyF Guo, X Cheng, E Hsieh, et al.
International Journal of STD & AIDS|April 6, 2011
Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infectionA Chamberland, M Sylla, M R Boulassel, et al.
HIV Medicine|June 4, 2014
Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapyJ-P Routy, J B Angel, M Patel, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2000
Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use. The Investigators of the Québec Primary HIV Infection StudyJ P Routy, P Vanhems, D Rouleau, et al.
Cell Transplantation|February 8, 2011
A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular diseaseM Bouchentouf, K Forner, J Cuerquis, et al.
Cell Transplantation|December 22, 2009
Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarctionM Bouchentouf, P Paradis, K A Forner, et al.
Clinical and Experimental Immunology|June 14, 2014
Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infectionM-A Jenabian, M Patel, I Kema, et al.
HIV Medicine|October 4, 2003
Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapyM R Boulassel, G H R Smith, N Gilmore, et al.
HIV Medicine|August 19, 2008
Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndromeN Voirin, J-P Routy, D Smith, et al.
Pageof 4